The TIGIT (Vibostolimab) Biosimilar Monoclonal Antibody (HDBS0027) is a cutting-edge tool for researchers investigating the TIGIT protein, a key player in immune regulation and a potential target for cancer therapy. This antibody, produced using advanced biosimilar technology, shows high specificity for TIGIT in human samples and is validated for use in various applications, including immunohistochemistry and flow cytometry.TIGIT, also known as T cell immunoreceptor with Ig and ITIM domains, is a co-inhibitory receptor that plays a crucial role in regulating T cell activity and immune responses. Its interaction with ligands such as CD155 and CD112R on antigen-presenting cells helps to dampen immune responses and promote immune tolerance.
Targeting TIGIT has emerged as a promising strategy for enhancing anti-tumor immune responses and overcoming immune evasion in cancer.The Anti-TIGIT (Vibostolimab) Biosimilar Monoclonal Antibody (HDBS0027) offers researchers a reliable tool to study TIGIT expression and function in various cell types and disease models. Its use can contribute to the development of novel immunotherapies for cancer and other immune-related disorders by uncovering the underlying mechanisms of TIGIT-mediated immune regulation.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
MK-7684
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
system_update_altDatasheetTiragolumab Biosimilar (TIGIT) Antibody (HDBS0026)The TIGIT (Tiragolumab Biosimilar) Monoclonal Antibody (HDbs0026) is a cutting-edge tool for re
system_update_altDatasheetBCMA Biosimilar Antibody (HDBS0016)The Anti-BCMA Monoclonal Antibody (HDbs0016) is a cutting-edge tool developed for researchers working in the f
system_update_altDatasheetMagrolimab Biosimilar, Igg1 Biosimilar (CD47) Antibody (HDBS0049)The CD47 Magroli Biosimilar (HDBS0049) is a cutting-edge product developed by As
